Navigation Links
BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer
Date:9/15/2009

mor masses is a major unmet need in a wide range of settings. It is our belief that, as a result, this technology has the potential to provide a broadly active new modality to substantially improve patient outcomes in a variety of hard-to-treat tumor types. "

Phase III Study Design

The Phase III study design agreed with the FDA follows directly from the design of the previous study. The Phase III study will also enroll previously untreated patients with locally advanced disease. The primary objective of the study will be to demonstrate a statistically significant increase in 2-year event free survival (i.e. relapse, progression, or death) for patients treated with chemoradiation together with OncoVEX (GM-CSF) as compared to patients treated with chemoradiation alone. The study will involve approximately 400 patients with approximately 200 in each arm.

Phase I/II Study Design and Results

In a Phase I/II study, OncoVEX (GM-CSF) was administered by direct injection, at three dose levels, into tumor containing lymph nodes in combination with standard first line chemo radiotherapy every three weeks for four cycles. All patients then went for surgery. Of the 17 patients enrolled, 16 had Stage IV N2 or N3 disease. OncoVEX (GM-CSF) was shown to be well tolerated with no significant side effects in addition to those associated with chemoradiation. With respect to efficacy, 93% of patients had a complete pathological response at surgery, with five patients achieving a complete response after only 2 or 3 virus doses. No patient to date has had a loco-regional recurrence in the neck at a median follow up of 30 months, and the disease specific survival rate is currently 82%.

Dr Robert Coffin, Founder and Chief Technology Officer, for BioVex, said:

"Loco-regional control is extremely important in head and neck cancer where loco regional progr
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma
2. BioVex Raises $40 Million in First Close of Series F Financing
3. BioVex to Present at the UBS Global Life Sciences Conference
4. BioVex Closes Second Round of Series E Financing
5. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
6. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
7. CardioDynamics Agrees to be Acquired by SonoSite for $1.35 Per Share
8. MannKind Agrees with Pfizer on the Purchase of Frankfurt Insulin Manufacturing Plant
9. PharmaNet Development Group Agrees to be Acquired by JLL Partners
10. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
11. Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... California, and BELLINGHAM, Washington, USA (PRWEB) September 02, 2014 ... International Year of Light and Light-based Technologies (IYL ... of top awards from SPIE, the international society ... Diego. Awards were presented to Levinson and Dudley along ... Gold Medal of the Society won by James Harrington, ...
(Date:9/2/2014)... engineered materials about a billionth of a meter in ... tiny, they can benefit human health, as in some ... with it through viruses, air pollution, traffic emissions, cosmetics, ... Washington University in St. Louis, led by Lan Yang, ... Electrical & Systems Engineering, and their collaborators at Tsinghua ...
(Date:9/2/2014)... Iowa (PRWEB) September 02, 2014 Press ... of ways to take advantage of the people and ... the schedule below are available throughout the day. Additionally, ... requests with POET and DSM representatives as well as ... interview requests is appreciated. , Please remember to ...
(Date:9/2/2014)... 2, 2014  Technology Applications International Corporation (the "Company" ... subsidiary Renuell Int,l, Inc. has signed an additional exclusive ... ("NASA") at the Johnson Space Center in ... tapplic.com/houstonphotos/ Charles J. ... to announce our latest, exclusive agreement with NASA. In ...
Breaking Biology Technology:Levinson, Dudley Win SPIE Directors’ and President’s Awards 2Levinson, Dudley Win SPIE Directors’ and President’s Awards 3Levinson, Dudley Win SPIE Directors’ and President’s Awards 4Engineers develop new sensor to detect tiny individual nanoparticles 2Engineers develop new sensor to detect tiny individual nanoparticles 3Press agenda for Project LIBERTY Grand Opening 2Press agenda for Project LIBERTY Grand Opening 3Press agenda for Project LIBERTY Grand Opening 4Press agenda for Project LIBERTY Grand Opening 5Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3
... The Drug Information Association (DIA) will host two co-located ... ... Horsham, PA (PRWEB) ... (DIA)] will host two co-located conferences from October 23-24 ...
... your lap lately, you probably noticed a burning sensation. ... more heat, which has to go somewhere in ... the University of Virginia,s School of Engineering and Applied ... solve the problem using nanoelectronics, considered the essential science ...
... 29 If one Delaware man,s vision,comes true, ... tumors as,they are with breast cancer, and to ... in the Game(R), an awareness campaign in his ... Kelly Heinz-Grundner Brain Tumor Foundation,and early this month ...
Cached Biology Technology:DIA Co-located Conference to Examine Outsourcing and Project Management Best Practices 2Engineers aim to solve 'burning' computer problem 2Delaware Man Spearheads Brain Tumor Awareness 2
(Date:9/2/2014)... the same DNA sequence their genetic information. How ... in the different parts of the body are so ... master plan, an additional regulatory layer exists that determines ... This mechanism involves modifications of genome-bound histone proteins or ... It acts on top of the genetic information and ...
(Date:9/2/2014)... in the September issue of The FASEB ... strategy to diagnose the leading cause of blindness ... has occurred. This advance involves quantifying the early ... of retinal vessels. Using new probes developed by ... molecular development of diabetic retinopathy. , "My goal ...
(Date:9/2/2014)... D.C., September 2, 2014 A study published ... Journal of the American Academy of Child and ... diagnosed with a psychiatric diagnosis had an increased ... to antipsychotics. , Using data from the nationwide ... Dr. Ren Ernst Nielsen, Psychiatry, Aalborg University Hospital, ...
Breaking Biology News(10 mins):Throwing a loop to silence gene expression 2Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2Risk of diabetes in children and adolescents exposed to antipsychotics 2
... world,s subspecies of tigers are now extinct. A new study ... a result of human activities, particularly the conversion of natural ... The study, conducted by Virginia Tech and World Wildlife ... investigate the use of different land cover types not ...
... People with schizophrenia who completed 80 hours of intensive, ... complex tasks that required them to distinguish their internal ... Neuron (2/22/12), a small clinical study conducted ... the University of California, San Francisco (UCSF), tested the ...
... Biology Department Chairman Thomas Chiles has been named the ... of Biology, the university announced today. Chiles, whose ... by the National Cancer Institute, the National Institutes of ... receive the endowed professorship, which will support his ongoing ...
Cached Biology News:Nowhere to hide: Study finds future of Sumatran tigers threatened by human disturbances 2Nowhere to hide: Study finds future of Sumatran tigers threatened by human disturbances 3Schizophrenia patients' ability to monitor reality may be helped by computerized training 2Schizophrenia patients' ability to monitor reality may be helped by computerized training 3Boston College names Thomas Chiles the Deluca Professor of Biology 2
... Chromogen system consists of [5-Bromo-4-Chloro-3-,Indolyl ... a single component,solution. The ready-to-use ... presence of alkaline phosphatase to ... background noise. ,The System Contains: ...
... Chromogen system consists of [5-Bromo-4-Chloro-3-,Indolyl ... a single component,solution. The ready-to-use ... presence of alkaline phosphatase to ... minimal background noise. ,The System ...
Mouse monoclonal antibody raised against a partial recombinant VEGFB. NCBI Entrez Gene ID = VEGFB...
... NH2 is primarily used for the preparation ... proteins for tracing. NH2-Reactive B-Phycoerythrin, a component ... and can easily make a covalent bond ... proteins without any activation process. Filtration Tube ...
Biology Products: